Suppr超能文献

晚期上皮性卵巢癌化疗后的最佳肿瘤细胞减灭术。

Optimal debulking following chemotherapy of advanced-stage epithelial ovarian carcinoma.

作者信息

Piura B, Glezerman M

机构信息

Division of Obstetrics and Gynecology, Soroka University Hospital, Beer-Sheva, Israel.

出版信息

J Surg Oncol. 1989 Apr;40(4):237-40. doi: 10.1002/jso.2930400407.

Abstract

We reviewed the records of 110 consecutive patients with advanced-stage epithelial ovarian carcinoma treated at the Soroka Medical Center, Beer-Sheva, Israel, from 1961-1987. Twenty patients (18.1%) had optimal debulking at initial laparotomy, 30 patients (27.2%) had nonoptimal debulking at initial laparotomy, 20 patients (18.1%) had an "inoperable" disease at initial laparotomy, and 40 patients (36.3%) had such poorly written records that no information about the degree of resectability at initial laparotomy could be obtained. Four patients, in whom the residual tumor left at initial laparotomy had responded to chemotherapy, had a second laparotomy. In all four patients optimal debulking surgery at second laparotomy was easy to perform and was successful. The value of a second laparotomy after a few cycles of chemotherapy in order to optimally debulk the residual tumor left at initial laparotomy is discussed. It is concluded that a second attempt of debulking surgery after chemotherapy has a respectable place in the management of patients with advanced-state epithelial ovarian carcinoma, but further research is needed.

摘要

我们回顾了1961年至1987年在以色列贝尔谢巴索罗卡医疗中心接受治疗的110例晚期上皮性卵巢癌患者的记录。20例患者(18.1%)在初次剖腹手术时实现了最佳肿瘤细胞减灭术,30例患者(27.2%)在初次剖腹手术时未实现最佳肿瘤细胞减灭术,20例患者(18.1%)在初次剖腹手术时患有“无法手术切除”的疾病,40例患者(36.3%)的记录书写得很差,以至于无法获得初次剖腹手术时可切除程度的信息。4例在初次剖腹手术时残留的肿瘤对化疗有反应的患者接受了二次剖腹手术。在所有4例患者中,二次剖腹手术时的最佳肿瘤细胞减灭术易于实施且取得了成功。本文讨论了在进行几个周期化疗后进行二次剖腹手术以对初次剖腹手术时残留的肿瘤进行最佳减瘤的价值。得出的结论是,化疗后再次进行肿瘤细胞减灭术在晚期上皮性卵巢癌患者的治疗中占有重要地位,但仍需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验